Cargando…
Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia
OBJECTIVE: There is a need for an improved biomarker for colorectal cancer (CRC) and advanced adenoma. We evaluated faecal microbial markers for clinical use in detecting CRC and advanced adenoma. DESIGN: We measured relative abundance of Fusobacterium nucleatum (Fn), Peptostreptococcus anaerobius (...
Autores principales: | Wong, Sunny H, Kwong, Thomas N Y, Chow, Tai-Cheong, Luk, Arthur K C, Dai, Rudin Z W, Nakatsu, Geicho, Lam, Thomas Y T, Zhang, Lin, Wu, Justin C Y, Chan, Francis K L, Ng, Simon S M, Wong, Martin C S, Ng, Siew C, Wu, William K K, Yu, Jun, Sung, Joseph J Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530471/ https://www.ncbi.nlm.nih.gov/pubmed/27797940 http://dx.doi.org/10.1136/gutjnl-2016-312766 |
Ejemplares similares
-
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
por: Goede, S Lucas, et al.
Publicado: (2013) -
Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers
por: Chiu, Han-Mo, et al.
Publicado: (2021) -
Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study
por: Cross, Amanda J, et al.
Publicado: (2019) -
Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer
por: Zorzi, Manuel, et al.
Publicado: (2022) -
Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms
por: Mowat, Craig, et al.
Publicado: (2016)